Almirall, S.A.;Draconis Pharma, S.L.;Laboratorios del. Dr. Esteve, S.A.
发明人:
申请号：
EP13382037.3
公开号：
EP2765128A1
申请日:
2013.02.07
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
The present invention belongs to the field of EP4 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP4 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP4 receptor as well as to pharmaceutical compositions comprising them.
